Canada· CA-DIN-00500895

NALCROM

A cromoglicic acid product containing cromolyn sodium, registered in Canada by LUPIN PHARMA CANADA LIMITED. The same ATC class is registered in 6 of our 19 countries.

ATC A07EB01

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedNALCROMATCA07EB01REGISTER NO.CA-DIN-00500895PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Cromoglicic acid is registered in 6 of 19 countries.

Countries holding a registration under ATC A07EB01 (cromoglicic acid), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 3 of them publish a price we can compare per daily dose

Cromoglicic acid · ATC A07EB01

6 / 19 countries

  • Canada
  • Czechiaprice
  • Finlandprice
  • Japan
  • Netherlands
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
CROMOLYN SODIUM
Manufacturer
LUPIN PHARMA CANADA LIMITED
Country
Canada (CA)
ATC code
A07EB01
ATC class
Cromoglicic acid
Defined daily dose
0.8 g, O
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

130 interactions on record for cromoglicic acid.

Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cromoglicic acid · interactions on record

130 records

  • 5 moderate
  • 125 info

Most severe, free to view

  • Insulin (human)A10AB01moderate
  • Insulin (human)A10AC01moderate
  • Insulin (human)A10AD01moderate
  • Insulin (human)A10AE01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cromoglicic acid in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cromoglicic acid products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Allergo-Comod, Allergocrom
  • Belgium · Allergo-Comod, Cromabak
  • Bulgaria · Lecrolyn Sine
  • Cyprus · Cromodal, Vividrin
  • Czechia · Allergo-Comod, Allergocrom
  • Germany · Allergoval, Cromo
  • Denmark · Lecrolyn Sine, Lomudal
  • Estonia · Lecrolyn, Lecrolyn Sine
  • Spain · Gastrofrenal
  • Finland · Lecrolyn, Lecrolyn Sine
  • France · Alairgix Rhinite Allergique, Allergocomod
  • United Kingdom (Northern Ireland) · Alleopti Allergy, Alleopti Hayfever
  • Greece · Allergotin, Chromoprol
  • Hungary · Lecrolyn, Taleum
  • Ireland · Opticrom, Opticrom Allergy
  • Iceland · Lecrolyn Sine, Lomudal
  • Italy · Brunicrom, Lecrosine
  • Lithuania · Lecrolyn, Lecrolyn Sine
  • Luxembourg · Allergo-Comod, Cromabak
  • Latvia · Lecrolyn Sine
  • Malta · Allergo-Comod, Allergotin
  • Netherlands · Allerg-Abak, Allergieneusspray Natriumcromoglicaat Etos
  • Norway · Lecrolyn Sine, Lomudal
  • Poland · Allergo-Comod, Allergocrom
  • Portugal · Allergocrom, Cromabak
  • Romania · Alergorom, Lecrolyn
  • Sweden · Allgil, Lecrolyn
  • Slovakia · Allergocrom, Lecrolyn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e8c3d1c0-5e7c-42d8-b289-d25b6bb067a2
GET /v1/drugs/e8c3d1c0-5e7c-42d8-b289-d25b6bb067a2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "00500895",
  "form": "CAPSULE",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "A07EB01",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "4114",
  "strengths": [
    "100 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "CROMOLYN SODIUM"
  ],
  "product_categorization": null
}

See everything about cromoglicic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.